Key Points
- CEO insider sale: Jason Murray sold 23,072 PACS Group shares at an average of $42.69, generating approximately $985,000. The transaction was made under a pre-arranged Rule 10b5-1 plan and reduced his holdings by just 0.04%.
- Strong recent performance: PACS Group reported quarterly EPS of $0.63, beating estimates by $0.09, while revenue reached $1.43 billion. Shares opened at $44.59, near their 12-month high of $49.49.
- Analysts remain bullish: The stock has a consensus “Buy” rating and an average price target of $58.80, with recent targets ranging from $57 to $62.
PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 4,758 shares of the business's stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $43.33, for a total transaction of $206,164.14. Following the transaction, the chief executive officer owned 54,574,866 shares of the company's stock, valued at approximately $2,364,728,943.78. This represents a 0.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total transaction of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total transaction of $984,943.68.
- On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The stock was sold at an average price of $42.56, for a total transaction of $858,562.88.
- On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The shares were sold at an average price of $42.94, for a total transaction of $1,021,242.02.
- On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The shares were sold at an average price of $42.39, for a total transaction of $1,024,015.23.
- On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The stock was sold at an average price of $43.90, for a total value of $2,600,811.60.
- On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The stock was sold at an average price of $43.92, for a total value of $4,010,159.52.
- On Wednesday, August 19th, Jason Murray sold 84,717 shares of PACS Group stock. The stock was sold at an average price of $44.26, for a total value of $3,749,574.42.
- On Tuesday, August 18th, Jason Murray sold 66,797 shares of PACS Group stock. The shares were sold at an average price of $44.18, for a total value of $2,951,091.46.
- On Monday, August 17th, Jason Murray sold 84,602 shares of PACS Group stock. The stock was sold at an average price of $44.16, for a total value of $3,736,024.32.
PACS Group Trading Up 2.1%
NYSE PACS opened at $44.59 on Thursday. PACS Group, Inc. has a one year low of $7.62 and a one year high of $49.49. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $7.06 billion, a P/E ratio of 25.92, a P/E/G ratio of 1.23 and a beta of -0.13. The stock's 50-day moving average is $44.74 and its 200-day moving average is $39.01.
PACS Group (NYSE:PACS - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion during the quarter, compared to analysts' expectations of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. Sell-side analysts anticipate that PACS Group, Inc. will post 2.36 earnings per share for the current fiscal year.
Hedge Funds Weigh In On PACS Group
Several hedge funds have recently made changes to their positions in PACS. Principal Financial Group Inc. acquired a new stake in shares of PACS Group in the first quarter valued at approximately $3,171,000. Smith Group Asset Management LLC bought a new position in PACS Group in the first quarter valued at $771,000. Maven Securities LTD bought a new position in PACS Group in the fourth quarter valued at $960,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in PACS Group in the first quarter valued at $6,762,000. Finally, Corient Private Wealth LLC increased its stake in PACS Group by 29.7% in the 4th quarter. Corient Private Wealth LLC now owns 170,052 shares of the company's stock valued at $6,528,000 after buying an additional 38,956 shares during the last quarter.
Wall Street Analyst Weigh In
PACS has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their price objective on shares of PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a report on Friday, September 4th. UBS Group upped their target price on shares of PACS Group from $57.00 to $60.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. Wall Street Zen lowered shares of PACS Group from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 8th. Zacks Research upgraded PACS Group from a "hold" rating to a "strong-buy" rating in a report on Monday, August 10th. Finally, Truist Financial set a $62.00 price target on PACS Group in a research note on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, PACS Group has an average rating of "Buy" and a consensus target price of $58.80.
Check Out Our Latest Analysis on PACS Group
About PACS Group
(
Get Free Report)
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
